Name
Baltic Medcom OÜ
Registry code
11415454
VAT number
EE101170114
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.08.2007 (17)
Financial year
01.10-30.09
Capital
2 556.00 €
Activity
47741 - Retail sale of medical and orthopaedic goods in specialised stores
1 282 537 €
176 102 €
14%
945 €
(estimate is approximate)
366 661 €
2
Submitted
No tax arrears
48%
32%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Villem Aruoja 13.05.1969 (55) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 05.05.2021 | 2020 05.05.2021 | 2021 02.05.2022 | 2022 25.03.2023 | 2023 08.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 694 145 € | 750 458 € | 850 844 € | 1 204 161 € | 1 282 537 € |
| Net profit (loss) for the period | 93 995 € | 92 174 € | 134 764 € | 74 606 € | 176 102 € |
| Profit Margin | 14% | 12% | 16% | 6% | 14% |
| Current Assets | 445 088 € | 507 349 € | 669 313 € | 431 330 € | 530 576 € |
| Fixed Assets | 17 860 € | 15 959 € | 14 657 € | 12 356 € | 20 060 € |
| Total Assets | 462 948 € | 523 308 € | 683 970 € | 443 686 € | 550 636 € |
| Current Liabilities | 148 769 € | 116 954 € | 142 852 € | 152 962 € | 183 975 € |
| Non Current Liabilities | 0 € | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 314 179 € | 406 354 € | 541 118 € | 290 724 € | 366 661 € |
| Employees | 2 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 428 324.36 € | 32 305.62 € | 2 989.82 € | 2 |
| 2023 Q4 | 384 503.56 € | 38 172.63 € | 3 111.2 € | 2 |
| 2023 Q3 | 366 577.21 € | 60 753.61 € | 9 847 € | 2 |
| 2023 Q2 | 354 996.23 € | 43 715.72 € | 2 847 € | 2 |
| 2023 Q1 | 648 776.83 € | 48 892 € | 2 643.94 € | 2 |
| 2022 Q4 | 310 774.94 € | 31 330.4 € | 2 237.82 € | 2 |
| 2022 Q3 | 443 264.77 € | 34 757.92 € | 2 237.82 € | 2 |
| 2022 Q2 | 496 888.94 € | 136 158.16 € | 2 237.82 € | 2 |
| 2022 Q1 | 456 352.31 € | 31 445.31 € | 2 467.86 € | 2 |
| 2021 Q4 | 426 576.22 € | 40 714.11 € | 2 652.49 € | 2 |
| 2021 Q3 | 338 875.58 € | 28 229.04 € | 2 237.82 € | 2 |
| 2021 Q2 | 208 263.85 € | 25 243.22 € | 2 237.82 € | 2 |
| 2021 Q1 | 342 396.64 € | 26 233.92 € | 2 237.82 € | 2 |
| 2020 Q4 | 328 756.55 € | 22 683.58 € | 2 237.82 € | 2 |
| 2020 Q3 | 227 531.75 € | 27 541.87 € | 2 237.82 € | 2 |
| 2020 Q2 | 433 112.9 € | 40 888.95 € | 1 887.45 € | 2 |
| 2020 Q1 | 327 685.2 € | 35 690.05 € | 2 361.39 € | 2 |
